These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 21745157)

  • 21. Characterization of G protein and phospholipase C-coupled agonist binding to the Y1 neuropeptide Y receptor in rat brain: sensitivity to G protein activators and inhibitors and to inhibitors of phospholipase C.
    Parker SL; Parker MS; Sweatman T; Crowley WR
    J Pharmacol Exp Ther; 1998 Jul; 286(1):382-91. PubMed ID: 9655883
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structure and dynamics of micelle-bound neuropeptide Y: comparison with unligated NPY and implications for receptor selection.
    Bader R; Bettio A; Beck-Sickinger AG; Zerbe O
    J Mol Biol; 2001 Jan; 305(2):307-29. PubMed ID: 11124908
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sub-population of cultured hippocampal astrocytes expresses neuropeptide Y Y(1) receptors.
    St-Pierre JA; Nouel D; Dumont Y; Beaudet A; Quirion R
    Glia; 2000 Mar; 30(1):82-91. PubMed ID: 10696147
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuropeptide Y and the retinal pigment epithelium: receptor subtypes, signaling, and bioelectrical responses.
    Ammar DA; Hughes BA; Thompson DA
    Invest Ophthalmol Vis Sci; 1998 Sep; 39(10):1870-8. PubMed ID: 9727410
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dimeric argininamide-type neuropeptide Y receptor antagonists: chiral discrimination between Y1 and Y4 receptors.
    Keller M; Kaske M; Holzammer T; Bernhardt G; Buschauer A
    Bioorg Med Chem; 2013 Nov; 21(21):6303-22. PubMed ID: 24074877
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functional role of the extracellular N-terminal domain of neuropeptide Y subfamily receptors in membrane integration and agonist-stimulated internalization.
    Lindner D; Walther C; Tennemann A; Beck-Sickinger AG
    Cell Signal; 2009 Jan; 21(1):61-8. PubMed ID: 18845246
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Establishment of robust functional assays for the characterization of neuropeptide Y (NPY) receptors: identification of 3-(5-benzoyl-thiazol-2-ylamino)-benzonitrile as selective NPY type 5 receptor antagonist.
    Dautzenberg FM; Higelin J; Pflieger P; Neidhart W; Guba W
    Neuropharmacology; 2005 Jun; 48(7):1043-55. PubMed ID: 15857631
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biophysical methods to study ligand-receptor interactions of neuropeptide Y.
    Bettio A; Beck-Sickinger AG
    Biopolymers; 2001; 60(6):420-37. PubMed ID: 12209475
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Receptor autoradiography as mean to explore the possible functional relevance of neuropeptides: focus on new agonists and antagonists to study natriuretic peptides, neuropeptide Y and calcitonin gene-related peptides.
    Dumont Y; Chabot JG; Quirion R
    Peptides; 2004 Mar; 25(3):365-91. PubMed ID: 15134861
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cloning and characterization of rabbit neuropeptide Y receptor subtypes.
    Umeda T; Kanatani A; Iwaasa H
    Peptides; 2009 Aug; 30(8):1441-7. PubMed ID: 19481128
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of the peptide binding requirements for the cloned human pancreatic polypeptide-preferring receptor.
    Gehlert DR; Schober DA; Beavers L; Gadski R; Hoffman JA; Smiley DL; Chance RE; Lundell I; Larhammar D
    Mol Pharmacol; 1996 Jul; 50(1):112-8. PubMed ID: 8700103
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of the C terminus in neuropeptide Y Y1 receptor desensitization and internalization.
    Holliday ND; Lam CW; Tough IR; Cox HM
    Mol Pharmacol; 2005 Mar; 67(3):655-64. PubMed ID: 15576634
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bivalent argininamide-type neuropeptide y y(1) antagonists do not support the hypothesis of receptor dimerisation.
    Keller M; Teng S; Bernhardt G; Buschauer A
    ChemMedChem; 2009 Oct; 4(10):1733-45. PubMed ID: 19672917
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative structural requirements of brain neuropeptide Y binding sites and vas deferens neuropeptide Y receptors.
    Martel JC; Fournier A; St-Pierre S; Dumont Y; Forest M; Quirion R
    Mol Pharmacol; 1990 Oct; 38(4):494-502. PubMed ID: 2172766
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of G proteins by neuropeptide Y and gamma-aminobutyric acid(B) receptor agonists in rat cerebral cortical membranes through distinct modes of action.
    Odagaki Y; Nishi N; Nakagawa S; Koyama T
    J Pharmacol Exp Ther; 1999 Dec; 291(3):1250-6. PubMed ID: 10565849
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interaction of NPY compounds with the rat glucocorticoid-induced receptor (GIR) reveals similarity to the NPY-Y2 receptor.
    Sah R; Parker SL; Sheriff S; Eaton K; Balasubramaniam A; Sallee FR
    Peptides; 2007 Feb; 28(2):302-9. PubMed ID: 17240481
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of fusion to Gα(i2) and co-expression with RGS proteins on pharmacological properties of human cannabinoid receptors CB₁R and CB₂R.
    Sutor S; Heilmann J; Seifert R
    J Pharm Pharmacol; 2011 Aug; 63(8):1043-55. PubMed ID: 21718288
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Y-receptor affinity modulation by the design of pancreatic polypeptide/neuropeptide Y chimera led to Y(5)-receptor ligands with picomolar affinity.
    Cabrele C; Wieland HA; Langer M; Stidsen CE; Beck-Sickinger AG
    Peptides; 2001 Mar; 22(3):365-78. PubMed ID: 11287091
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Application of the guanidine-acylguanidine bioisosteric approach to argininamide-type NPY Y₂ receptor antagonists.
    Pluym N; Brennauer A; Keller M; Ziemek R; Pop N; Bernhardt G; Buschauer A
    ChemMedChem; 2011 Sep; 6(9):1727-38. PubMed ID: 21692185
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The anterograde transport of the human neuropeptide Y2 receptor is regulated by a subtype specific mechanism mediated by the C-terminus.
    Walther C; Lotze J; Beck-Sickinger AG; Mörl K
    Neuropeptides; 2012 Dec; 46(6):335-43. PubMed ID: 23020974
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.